May 14, 2012 — Using a concentrated, highly targeted dose of radiation to the breast has equally as good results as irradiating the whole area, with no adverse effects on survival and a much better cosmetic outcome, Hungarian researchers have found. Reporting the 10-year results of a randomised trial, Professor Csaba Polgár, M.D., director of the Centre for Radiotherapy, National Institute of Oncology, Budapest, told the World Congress of Brachytherapy (WCB) that he believes accelerated partial breast irradiation (APBI) could be offered to many more breast cancer patients, resulting in fewer side effects and major cost savings to healthcare systems.
If you enjoy this content, please share it with a colleague
- Read more about APBI as Good as Whole Breast RT in Early Stage Cancer
- Log in or register to post comments